HLA-DRB1 and myeloid sarcoma: Furthermore, the interaction SF analysis confirmed a significant statistical epistasis between CD33 rs3865444 A and HLA-DRB1*15:01 alleles, suggesting that they display an antagonistic interaction in the context of MS risk.